You combat multidrug-resistant organisms (MDROs) and bacterial infection daily, so you know the epidemiology is evolving into a global health crisis. However, recently introduced treatments-with emerging options in the pipeline-mark a new approach in the fight against antimicrobial resistance.
Join Dr. Jean Patel, principal scientist of scientific affairs at Beckman Coulter, as she presents the status of current drugs to fight bacterial infection, updated breakpoints and an antimicrobial treatment forecast. After watching this webinar, you will be better equipped to improve patient outcomes and advance antimicrobial stewardship by understanding the benefits and limitations of:
- Currently available MDRO treatment options
- Emerging Gram-positive and Gram-negative bacteria
- Updated susceptibility-testing strategies
P.A.C.E. credit is available for your participation*
Ideal For: Microbiologist, Antibiotic Stewardship Committee Member, Lab Director, Medical Director, Physician, Pathologist, Pharmacist, Infectious Disease Doctor, Infectious Disease Pharmacist, Infection Control Specialist
Presenter: Jean B. Patel, Ph.D., D(ABMM)
Dr. Jean Patel currently serves as the principal scientist, scientific affairs, at Beckman Coulter. Prior to her role at Beckman Coulter, Dr. Patel served as the science team lead, antibiotic resistance coordination and strategy unit, at the Centers for Disease Control (CDC), where she led implementation of its Antibiotic Resistance Laboratory Network and the CDC and FDA Antibiotic Resistance Isolate Bank.
Dr. Patel has served as chair and vice chair of the Clinical and Laboratory Standards Institute Subcommittee for Antimicrobial Susceptibility Testing and works with the World Health Organization to develop technical guidance for detecting resistance and strengthening global surveillance of antimicrobial resistance.